No Data
No Data
No Data
No Data
No Data
ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
iCAD, Inc. (NASDAQ: ICAD) announced today it will showcase its ProFound Breast Health Suite of AI solutions, including the newly released ProFound Cloud, powered by Google Cloud and Google Health AI architecture, while also highlighting its recently announced partnership with Densitas, a global leader in AI solutions for breast cancer screening, at the Society for Breast Imaging (SBI) annual symposium, April 11-14 in Montreal, Canada.
GlobeNewswireApr 11 08:00 ET
Express News | ICAD And Densitas Partner To Enhance Precision Breast Health With Leading AI Solutions
Moomoo 24/7Apr 9 08:01 ET
ICAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
iCAD, Inc. (NASDAQ: ICAD) announced today that new data indicates its AI-powered solution effectively uncovers calcium deposits in the breast vessels.
GlobeNewswireApr 8 16:29 ET
Express News | ICad Shares Are Trading Higher After the Company Announced a Collaboration With Rad-AID to Introduce Mammography AI-based Decision Support in LMICs
Moomoo 24/7Apr 3 11:28 ET
Express News | ICAD Partners With RAD-AID To Advance Breast Cancer Detection Using AI In Underserved Regions
Moomoo 24/7Apr 3 08:06 ET
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
NASHUA, N.H., April 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced commercial availability of ProFound Cloud. The
GlobeNewswireApr 2 08:00 ET
No Data
No Data